However, in non-small cell lung cancer (NSCLC) with KRAS mutation and LKB1 deletion, the expression of carbamoyl phosphate synthase (CPS) 1 increases; this change leads to an increase in the CP, which moves from mitochondria to the cytoplasm. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.